| Product NDC: | 0409-7419 |
| Proprietary Name: | LMD in Sodium Chloride |
| Non Proprietary Name: | DEXTRAN 40 |
| Active Ingredient(s): | 10 g/100mL & nbsp; DEXTRAN 40 |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-7419 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA720562 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110308 |
| Package NDC: | 0409-7419-03 |
| Package Description: | 12 POUCH in 1 CASE (0409-7419-03) > 1 BAG in 1 POUCH > 500 mL in 1 BAG |
| NDC Code | 0409-7419-03 |
| Proprietary Name | LMD in Sodium Chloride |
| Package Description | 12 POUCH in 1 CASE (0409-7419-03) > 1 BAG in 1 POUCH > 500 mL in 1 BAG |
| Product NDC | 0409-7419 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DEXTRAN 40 |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110308 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | DEXTRAN 40 |
| Strength Number | 10 |
| Strength Unit | g/100mL |
| Pharmaceutical Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA] |